Close Menu
August 28, 2019
Sponsored by
Horizon Discovery

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases


Director of the Center for Advance Genome Engineering,
St. Jude Children’s Research Hospital

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.

Genome editing using the CRISPR-Cas9 platform enables precise genetic manipulations within complex genomes. Although wild-type Streptococcus pyogenes Cas9 (SpCas9) was the first detailed CRISPR platform, this widely used nuclease is still limited by the canonical 5’-NGG-3’ protospacer adjacent motif required for SpCas9 binding and cleavage.

In this webinar, Shondra Miller of St. Jude Children's Research Hospital will discuss the pros and cons of several Cas9 variants and orthologues and how these alternative nucleases can be applied to genome editing workflows.

Sponsored by

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.

Sponsored by
Qiagen: Nov 16, 2014

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Sponsored by

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.